CSBR: Champions Oncology, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 68.38
Enterprise Value ($M) 63.91
Book Value ($M) -2.06
Book Value / Share -0.15
Price / Book -33.22
NCAV ($M) -15.65
NCAV / Share -1.15
Price / NCAV -4.37

Profitability (mra)
Return on Invested Capital (ROIC) -1.71
Return on Assets (ROA) -0.27
Return on Equity (ROE) -1.38

Liquidity (mrq)
Quick Ratio 0.60
Current Ratio 0.60

Balance Sheet (mrq) ($M)
Current Assets 13.20
Assets 26.79
Liabilities 28.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G Tocqueville Asset Management L.p. 5.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-15 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-12-13 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-09-13 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-07-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 8 3,182 0.25
2024-03-26 18 5,272 0.34
2024-03-25 1 6,935 0.01

(click for more detail)

Similar Companies
CRDF – Cardiff Oncology, Inc. CRIS – Curis, Inc.
CRVO – CervoMed Inc. CTXR – Citius Pharmaceuticals, Inc.
CUE – Cue Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io